{"id":"https://openalex.org/W4210693031","doi":"https://doi.org/10.1177/10781552221074719","title":"Cecal volvulus associated with carfilzomib use for al amyloidosis","display_name":"Cecal volvulus associated with carfilzomib use for al amyloidosis","publication_year":2022,"publication_date":"2022-01-28","ids":{"openalex":"https://openalex.org/W4210693031","doi":"https://doi.org/10.1177/10781552221074719","pmid":"https://pubmed.ncbi.nlm.nih.gov/35089100"},"language":"en","primary_location":{"id":"doi:10.1177/10781552221074719","doi":"https://doi.org/10.1177/10781552221074719","is_oa":false,"landing_page_url":"https://doi.org/10.1177/10781552221074719","pdf_url":null,"source":{"id":"https://openalex.org/S66425452","display_name":"Journal of Oncology Pharmacy Practice","issn_l":"1078-1552","issn":["1078-1552","1477-092X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Oncology Pharmacy Practice","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4210693031"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032142893","display_name":"Shahaf Tuler","orcid":"https://orcid.org/0000-0002-2695-6153","observed_orcids":["https://orcid.org/0000-0002-2695-6153"]},"institutions":[{"id":"https://openalex.org/I1327543694","display_name":"Eisenhower Medical Center","ror":"https://ror.org/050wjeh45","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1327543694"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Shahaf Tuler","raw_affiliation_strings":["Eisenhower Health","Department of Medicine, Eisenhower Health, Rancho Mirage, CA, USA"],"raw_orcid":"https://orcid.org/0000-0002-2695-6153","affiliations":[{"raw_affiliation_string":"Eisenhower Health","institution_ids":[]},{"raw_affiliation_string":"Department of Medicine, Eisenhower Health, Rancho Mirage, CA, USA","institution_ids":["https://openalex.org/I1327543694"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062380029","display_name":"Jaspreet Kaur","orcid":"https://orcid.org/0000-0002-4125-5355","observed_orcids":["https://orcid.org/0000-0002-4125-5355"]},"institutions":[{"id":"https://openalex.org/I1327543694","display_name":"Eisenhower Medical Center","ror":"https://ror.org/050wjeh45","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1327543694"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaspreet Kaur","raw_affiliation_strings":["Eisenhower Health","Department of Medicine, Eisenhower Health, Rancho Mirage, CA, USA"],"raw_orcid":"https://orcid.org/0000-0002-4125-5355","affiliations":[{"raw_affiliation_string":"Eisenhower Health","institution_ids":[]},{"raw_affiliation_string":"Department of Medicine, Eisenhower Health, Rancho Mirage, CA, USA","institution_ids":["https://openalex.org/I1327543694"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001190634","display_name":"Constantin A Dasanu","orcid":"https://orcid.org/0000-0003-0425-8394","observed_orcids":["https://orcid.org/0000-0003-0425-8394"]},"institutions":[{"id":"https://openalex.org/I1327543694","display_name":"Eisenhower Medical Center","ror":"https://ror.org/050wjeh45","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1327543694"]},{"id":"https://openalex.org/I2800935791","display_name":"UC San Diego Health System","ror":"https://ror.org/01kbfgm16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Constantin A. Dasanu","raw_affiliation_strings":["Eisenhower Health","UC San Diego Health, San Diego, CA, USA","Lucy Curci Cancer Center, Eisenhower Health, Rancho Mirage, CA, USA"],"raw_orcid":"https://orcid.org/0000-0003-0425-8394","affiliations":[{"raw_affiliation_string":"Eisenhower Health","institution_ids":[]},{"raw_affiliation_string":"UC San Diego Health, San Diego, CA, USA","institution_ids":["https://openalex.org/I2800935791"]},{"raw_affiliation_string":"Lucy Curci Cancer Center, Eisenhower Health, Rancho Mirage, CA, USA","institution_ids":["https://openalex.org/I1327543694"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5032142893"],"corresponding_institution_ids":["https://openalex.org/I1327543694"],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":0.2438,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.48128673,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"28","issue":"5","first_page":"1230","last_page":"1233"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","score":0.8500999808311462,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","score":0.8500999808311462,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12150","display_name":"Intestinal Malrotation and Obstruction Disorders","score":0.10809999704360962,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.01209999993443489,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cecal-volvulus","display_name":"cecal volvulus","score":0.9829999804496765},{"id":"https://openalex.org/keywords/carfilzomib","display_name":"carfilzomib","score":1.0},{"id":"https://openalex.org/keywords/al-amyloidosis","display_name":"AL amyloidosis","score":0.9449999928474426},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.8109999895095825},{"id":"https://openalex.org/keywords/gastrointestinal-toxicity","display_name":"gastrointestinal toxicity","score":0.9589999914169312},{"id":"https://openalex.org/keywords/hemicolectomy","display_name":"hemicolectomy","score":0.859000027179718},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5180000066757202},{"id":"https://openalex.org/keywords/naranjo-probability-scale","display_name":"Naranjo probability scale","score":0.7369999885559082},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.675000011920929}],"concepts":[{"id":"https://openalex.org/C2780108899","wikidata":"https://www.wikidata.org/wiki/Q15366934","display_name":"Carfilzomib","level":4,"score":0.9907283782958984},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8985700011253357},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6189324855804443},{"id":"https://openalex.org/C2779951007","wikidata":"https://www.wikidata.org/wiki/Q816798","display_name":"Amyloidosis","level":2,"score":0.5126940011978149},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.44869235157966614},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4239461421966553},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4156635105609894},{"id":"https://openalex.org/C2778367456","wikidata":"https://www.wikidata.org/wiki/Q7251235","display_name":"Proteasome inhibitor","level":3,"score":0.3903718888759613},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3744957447052002}],"mesh":[{"descriptor_ui":"D000075363","descriptor_name":"Immunoglobulin Light-chain Amyloidosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045822","descriptor_name":"Intestinal Volvulus","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D045822","descriptor_name":"Intestinal Volvulus","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D061988","descriptor_name":"Proteasome Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/10781552221074719","doi":"https://doi.org/10.1177/10781552221074719","is_oa":false,"landing_page_url":"https://doi.org/10.1177/10781552221074719","pdf_url":null,"source":{"id":"https://openalex.org/S66425452","display_name":"Journal of Oncology Pharmacy Practice","issn_l":"1078-1552","issn":["1078-1552","1477-092X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Oncology Pharmacy Practice","raw_type":"journal-article"},{"id":"pmid:35089100","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35089100","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W1802491530","https://openalex.org/W2067978628","https://openalex.org/W2070335603","https://openalex.org/W2150432678","https://openalex.org/W2338117980","https://openalex.org/W2557975627","https://openalex.org/W2790541134","https://openalex.org/W2896369083","https://openalex.org/W2935332994","https://openalex.org/W2965224381"],"related_works":["https://openalex.org/W6921073946","https://openalex.org/W2965224381","https://openalex.org/W2346841107","https://openalex.org/W2245893839","https://openalex.org/W2186711330","https://openalex.org/W2771209907","https://openalex.org/W2022566575","https://openalex.org/W2765886349","https://openalex.org/W2527713631","https://openalex.org/W2984640790"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Proteasome":[1],"inhibitors":[2],"have":[3,26,106],"emerged":[4],"as":[5],"quintessential":[6],"therapies":[7],"for":[8],"light-chain":[9],"(AL)":[10],"amyloidosis":[11,64],"and":[12,115,131],"multiple":[13],"myeloma":[14],"in":[15,85],"the":[16,86,118,123,132,145],"last":[17],"decade.":[18],"While":[19],"these":[20],"agents":[21],"are":[22,38,49],"highly":[23],"effective,":[24],"reports":[25],"also":[27],"documented":[28,140],"toxicities":[29,37],"affecting":[30],"various":[31],"organ":[32],"systems.":[33],"Whereas":[34],"gastrointestinal":[35],"(GI)":[36],"a":[39,56,60,139],"relatively":[40],"common":[41],"occurrence":[42],"with":[43,62,74,117,134,138],"proteasome":[44],"inhibitors,":[45],"severe":[46,77,108],"GI":[47,78,109],"complications":[48],"exceedingly":[50],"rare.":[51],"CASE":[52],"REPORT:":[53],"We":[54],"describe":[55],"unique":[57],"case":[58],"of":[59,72,142,155],"patient":[61,92],"AL":[63],"who":[65],"developed":[66],"cecal":[67],"volvulus":[68,130],"after":[69],"four":[70],"weeks":[71],"treatment":[73,120,133],"carfilzomib.":[75,102],"This":[76],"manifestation":[79],"has":[80,157],"not":[81,105],"been":[82],"previously":[83],"described":[84],"literature.":[87],"MANAGEMENT":[88],"AND":[89],"OUTCOME:":[90],"The":[91,127,149],"required":[93],"right":[94],"hemicolectomy.":[95],"After":[96],"clinical":[97],"recovery,":[98],"she":[99],"restarted":[100],"reduced-dose":[101],"She":[103],"did":[104],"any":[107],"side":[110],"effects":[111],"following":[112],"dose":[113],"reduction,":[114],"continues":[116],"current":[119],"regimen":[121],"to":[122,159],"present":[124],"day.":[125],"DISCUSSION/CONCLUSION:":[126],"causality":[128],"between":[129],"carfilzomib":[135,156],"was":[136],"probable,":[137],"score":[141],"6":[143],"on":[144],"Naranjo":[146],"probability":[147],"nomogram.":[148],"exact":[150],"mechanism":[151],"behind":[152],"this":[153],"effect":[154],"yet":[158],"be":[160],"elucidated.":[161]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-02-08T00:00:00"}